Copied Risk-sharing in the Pharmaceutical Industry
Risk-sharing in the Pharmaceutical Industry
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year.
Price Comparison
| Seller | Contact Seller | List Price | On Sale | Shipping | Best Promo | Final Price | Volume Discount | Financing | Availability | Seller's Page |
|---|---|---|---|---|---|---|---|---|---|---|
|
BEST PRICE 1 Product Purchase
|
|
$84.99 | $84.99 |
|
$84.99 | See Site | In stock | Visit Store |
Reviews
Questions & Answers
Pigments in Vegetables
$169.00
Programmieren mit FORTRAN
$59.99
Introducing Microsoft Orleans
$44.99
Terremoto
$3.74
Mathematical Logic
$39.99
Kriminalitt im Grenzgebiet
$100.00
Die Lehre vom Wirtschaftsbetrieb (Allgemeine Betbiebswirtschaftslehre)
$59.99
Towards A European Nationality
$109.99
Capitalism, The American Empire, and Neoliberal Globalization
$79.99
Consumer Confusion im Handel
$64.99
More Harm than Good?
$22.99
Indien: Wirtschaft, Verfassung, Politik
$74.99
Sustainable Agriculture Reviews
$219.99
Umweltschutz-Management und ko-Auditing
$69.95
Traces of Differential Forms and Hochschild Homology
$29.99
Biological Reactive Intermediates
$109.99
Internationales Gemeinschaftsrecht
$129.00
Risikomanagement in 10 Schritten
$17.99
Manual of Aesthetic Surgery 1
$74.99
International Handbook of English Language Teaching
$429.00
Musik und Internet
$79.99
Johan Galtung
$79.99
Lineare Kirchhoff-Netzwerke
$24.99
Distributions in the Physical and Engineering Sciences, Volume 3
$39.99
Design of Efficient and Safe Neural Stimulators
$129.99
Mineral Processing at a Crossroads
$219.99
Rubidomycin
$54.99
Lebenslanges Lernen und erziehungswissenschaftliche Biographieforschung
$39.99
Produktdatenmanagement Anforderungen und Lsungen
$69.99
Public Health Intelligence
$159.99
Earthquake Forecasting and Warning
$219.99
Enhanced Virtual Prototyping
$129.99
Subjekt Bildung
$59.99
Die Bestandteile der Lebensmittel
$99.99
Separable Programming
$109.99
Mechanisms in B-Cell Neoplasia 1988
$109.99
Expert Oracle Application Express
$54.99
The Welfare of Fish
$129.99
Compilers and Operating Systems for Low Power
$84.99
Quantifying Aesthetics of Visual Design Applied to Automatic Design
$84.99
